Literature DB >> 8947095

Progesterone treatment in chylothorax associated with pulmonary tuberous sclerosis.

V Jounieaux1, S Druelle, I Mayeux, E Grimault, J C Charet.   

Abstract

We report the case of a young woman with tuberous sclerosis who developed a chylous pleural effusion after several invasive procedures for treatment of recurring pneumothoraces. Oophorectomy was rejected by the patient and progesterone therapy initiated. Medroxyprogesterone acetate administration led to a complete disappearance of the chylothorax in 8 months. The patient was kept on therapy, and no recurrence of pleural effusion has been observed up to the present (22 months follow-up). However, a progressive deterioration in pulmonary function was observed, with a significant decrease in pulmonary transfer factor and increase in airway obstruction. In conclusion, this report demonstrates an objective benefit of progesterone therapy on chylous effusion associated with pulmonary tuberous sclerosis.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8947095     DOI: 10.1183/09031936.96.09112423

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  1 in total

1.  VATS therapy of chylothorax caused by leiomyomatosis complicated with tuberous sclerosis complex.

Authors:  Adrienn Csiszkó; György Herr; Sándor Sz Kiss; Judit Hallay; Zoltán Gyöngyösi; Zsolt Szentkereszty
Journal:  J Minim Access Surg       Date:  2013-04       Impact factor: 1.407

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.